KR20010108108A - 프로디지오신의 당뇨병 예방 및 치료용 조성물 - Google Patents
프로디지오신의 당뇨병 예방 및 치료용 조성물 Download PDFInfo
- Publication number
- KR20010108108A KR20010108108A KR1020017009042A KR20017009042A KR20010108108A KR 20010108108 A KR20010108108 A KR 20010108108A KR 1020017009042 A KR1020017009042 A KR 1020017009042A KR 20017009042 A KR20017009042 A KR 20017009042A KR 20010108108 A KR20010108108 A KR 20010108108A
- Authority
- KR
- South Korea
- Prior art keywords
- prodigiosin
- diabetes
- nod mice
- cells
- insulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (1)
- 세라시아 마르세센스에서 분리한 하기와 같은 구조식을 갖는 프로디지오신을 유효성분으로 포함하는 당뇨병 예방 및 치료용 조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000007139A KR20010081515A (ko) | 2000-02-15 | 2000-02-15 | 프로디지오신의 당뇨병 예방 및 치료용 조성물 |
KR1020000007139 | 2000-02-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010108108A true KR20010108108A (ko) | 2001-12-07 |
KR100406848B1 KR100406848B1 (ko) | 2003-11-21 |
Family
ID=19646694
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020000007139A KR20010081515A (ko) | 2000-02-15 | 2000-02-15 | 프로디지오신의 당뇨병 예방 및 치료용 조성물 |
KR10-2001-7009042A KR100406848B1 (ko) | 2000-02-15 | 2000-08-10 | 프로디지오신의 당뇨병 예방 및 치료용 조성물 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020000007139A KR20010081515A (ko) | 2000-02-15 | 2000-02-15 | 프로디지오신의 당뇨병 예방 및 치료용 조성물 |
Country Status (7)
Country | Link |
---|---|
US (1) | US6638968B1 (ko) |
EP (1) | EP1251847B1 (ko) |
KR (2) | KR20010081515A (ko) |
AT (1) | ATE354361T1 (ko) |
AU (1) | AU6479000A (ko) |
DE (1) | DE60033569T2 (ko) |
WO (1) | WO2001060361A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101995768B1 (ko) * | 2019-03-13 | 2019-07-03 | (주)엔솔바이오사이언스 | 신규 펩타이드 및 그 용도 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040014987A1 (en) * | 2000-01-26 | 2004-01-22 | Gemin X Biotechnologies Inc. | Pyrrole-Type compounds, compositions, and methods for treating cancer or viral diseases |
KR100392225B1 (ko) * | 2001-04-19 | 2003-07-22 | 한국생명공학연구원 | 류머티스 관절염 치료용 프로디지오신 조성물 |
ES2304135T3 (es) * | 2001-07-18 | 2008-09-16 | Gemin X Biotechnologies Inc. | Compuestos tipo pirrol, composiciones y metodos para tratar el cancer, tratar enfermedades virales y causar inmunosupresion. |
DE102013006341A1 (de) | 2013-04-15 | 2014-10-16 | Yoen Ok Roth | Pharmazeutisches Erzeugnis zur Behandlung von Augenerkrankungen |
WO2017177216A1 (en) * | 2016-04-08 | 2017-10-12 | Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center | Prodigiosin analogs |
US10870640B2 (en) | 2016-04-08 | 2020-12-22 | Institute For Cancer Research | Prodigiosin analogs and methods of use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9326284D0 (en) * | 1993-12-23 | 1994-02-23 | Erba Carlo Spa | Pyrrolydenemethyl-derivatives and process for their preparation |
GB9603212D0 (en) * | 1996-02-15 | 1996-04-17 | Pharmacia Spa | Process for the preparation of 2,2'-bipyrrolyl-pyrromethane derivatives |
KR100252197B1 (ko) | 1997-09-20 | 2000-04-15 | 박호군 | 세라시아 마르세센스 균주의 배양액으로 부터 분리한 면역억제제용 프로디지오신 |
GB9802745D0 (en) * | 1998-02-09 | 1998-04-08 | Pharmacia & Upjohn Spa | Benzyloxy prodigiosine compounds |
-
2000
- 2000-02-15 KR KR1020000007139A patent/KR20010081515A/ko active Search and Examination
- 2000-08-10 AT AT00952026T patent/ATE354361T1/de not_active IP Right Cessation
- 2000-08-10 KR KR10-2001-7009042A patent/KR100406848B1/ko active IP Right Grant
- 2000-08-10 EP EP00952026A patent/EP1251847B1/en not_active Expired - Lifetime
- 2000-08-10 DE DE60033569T patent/DE60033569T2/de not_active Expired - Lifetime
- 2000-08-10 US US10/149,139 patent/US6638968B1/en not_active Expired - Lifetime
- 2000-08-10 AU AU64790/00A patent/AU6479000A/en not_active Abandoned
- 2000-08-10 WO PCT/KR2000/000881 patent/WO2001060361A1/en active IP Right Grant
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101995768B1 (ko) * | 2019-03-13 | 2019-07-03 | (주)엔솔바이오사이언스 | 신규 펩타이드 및 그 용도 |
WO2020184901A1 (en) * | 2019-03-13 | 2020-09-17 | Ensol Biosciences, Inc. | Novel peptide and use thereof |
CN113508126A (zh) * | 2019-03-13 | 2021-10-15 | 因首生物科学有限公司 | 新型肽及其用途 |
CN113508126B (zh) * | 2019-03-13 | 2023-09-29 | 因首生物科学有限公司 | 新型肽及其用途 |
Also Published As
Publication number | Publication date |
---|---|
US6638968B1 (en) | 2003-10-28 |
EP1251847A1 (en) | 2002-10-30 |
WO2001060361A1 (en) | 2001-08-23 |
KR20010081515A (ko) | 2001-08-29 |
ATE354361T1 (de) | 2007-03-15 |
DE60033569D1 (de) | 2007-04-05 |
AU6479000A (en) | 2001-08-27 |
DE60033569T2 (de) | 2007-10-31 |
EP1251847A4 (en) | 2004-11-10 |
EP1251847B1 (en) | 2007-02-21 |
KR100406848B1 (ko) | 2003-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lin et al. | Evaluation of the antioxidant and hepatoprotective activity of Terminalia catappa | |
Keung et al. | Daidzin suppresses ethanol consumption by Syrian golden hamsters without blocking acetaldehyde metabolism. | |
US20080026987A1 (en) | Use of Liver-Selective Glucokinase Activators | |
EP1014980A1 (en) | Use of nitroxides for the treatment of essential hypertension | |
KR100406848B1 (ko) | 프로디지오신의 당뇨병 예방 및 치료용 조성물 | |
KR20070095900A (ko) | 세포 내 글루타티온 및 atp의 전달 향상을 통하여저산소증을 치료하기 위한 리보스-시스테인의 용도 | |
Lee et al. | APX-115, a pan-NADPH oxidase inhibitor, protects development of diabetic nephropathy in podocyte specific NOX5 transgenic mice | |
Teunissen et al. | Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo | |
CN111437393A (zh) | 用于糖尿病及其并发症治疗的联合用药及其药物组合物 | |
KR100441643B1 (ko) | 펠리누스 린테우스에서 분리한 다당류의 당뇨병 예방 및치료용 조성물 | |
US7338941B2 (en) | Pharmaceutical compositions for lowering blood glucose and blood cholesterol levels | |
RU2585372C1 (ru) | Фармацевтическая композиция для ингибирования аутофагии двигательных нейронов и её применение | |
EP1392285B1 (de) | Arzneimittel enthaltend einen effektor des glutathionmetabolismus zusammen mit alpha-liponsäure im rahmen der nierenersatztherapie | |
EP2528595A1 (de) | Verbindungen zur verwendung bei der behandlung von erkrankungen | |
EP1529529B1 (de) | Verwendung mindestens eines Effektors des Glutathionmetabolismus zusammen mit Alpha-Liponsäure zur immunmodulatorischen, abwehrsteigernden und/oder entzündungshemmenden Behandlung | |
KR100441644B1 (ko) | 참당귀에서 분리한 다당류의 당뇨병 예방 및 치료용 조성물 | |
CN104582730B (zh) | 一种提高线粒体代谢机能的方法及应用 | |
Chen et al. | Beneficial effects of sanguisorbae radix in renal dysfunction caused by endotoxin in vivo | |
JP2000515516A (ja) | ニコチン代謝の調節方法 | |
AU618838B2 (en) | Use of castanospermine as an anti-inflammatory and immunosuppressant agent | |
EP1523312A1 (fr) | Elevation du taux d' heme oxygynase avec des derives de la rheine | |
WO2017209270A1 (ja) | 25-ヒドロキシコレステロール又はその類縁体コレステロールを有効成分として含有してなる、活性化されたt細胞及び/又はb細胞に選択的な細胞死誘導剤又は細胞死促進剤 | |
KR19990066786A (ko) | 베르겐닌 및 그 유도체를 유효성분으로 하는 간기능 개선제 | |
US6214357B1 (en) | Treatment of diabetes | |
KR100392225B1 (ko) | 류머티스 관절염 치료용 프로디지오신 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121112 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20130930 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20141015 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20151006 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20161025 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20171113 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20180918 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20191024 Year of fee payment: 17 |